Research ArticleArticle
2-Fluoro-L-histidine, an Inhibitor of Enzyme Induction
DAVID C. KLEIN, KENNETH L. KIRK, JOAN L. WELLER, TAKAMI OKA, ANDREW PARFITT and IDA S. OWENS
Molecular Pharmacology September 1976, 12 (5) 720-730;
DAVID C. KLEIN
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
KENNETH L. KIRK
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
JOAN L. WELLER
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
TAKAMI OKA
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
ANDREW PARFITT
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
IDA S. OWENS
Section on Physiological Controls, Laboratory of Biomedical Sciences, and Section on Developmental Pharmacology, Neonatal and Pediatric Medicine Branch, National Institute of Child Health and Human Development; and Section on Biochemical Mechanisms, Laboratory of Chemistry, and Section on Intermediary Metabolism, Laboratory of Biochemistry and Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 12, Issue 5
1 Sep 1976
Research ArticleArticle
2-Fluoro-L-histidine, an Inhibitor of Enzyme Induction
DAVID C. KLEIN, KENNETH L. KIRK, JOAN L. WELLER, TAKAMI OKA, ANDREW PARFITT and IDA S. OWENS
Molecular Pharmacology September 1, 1976, 12 (5) 720-730;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement